Ausgabe 1/2018
Inhalt (27 Artikel)
Occult breast cancer may originate from ectopic breast tissue present in axillary lymph nodes
Mitsuo Terada, Yayoi Adachi, Masataka Sawaki, Masaya Hattori, Akiyo Yoshimura, Gondo Naomi, Haruru Kotani, Madoka Iwase, Ayumi Kataoka, Sakura Onishi, Kayoko Sugino, Makiko Mori, Nanae Horisawa, Eiichi Sasaki, Yasushi Yatabe, Hiroji Iwata
CDK4/6 inhibitors in advanced hormone receptor-positive/HER2-negative breast cancer: a systematic review and meta-analysis of randomized trials
Carlo Messina, Carlo Cattrini, Giulia Buzzatti, Luigi Cerbone, Elisa Zanardi, Marco Messina, Francesco Boccardo
PARP3 inhibitors ME0328 and olaparib potentiate vinorelbine sensitization in breast cancer cell lines
Bahram Sharif-Askari, Lilian Amrein, Raquel Aloyz, Lawrence Panasci
Field template-based design and biological evaluation of new sphingosine kinase 1 inhibitors
Heba Alshaker, Shyam Srivats, Danielle Monteil, Qi Wang, Caroline M. R. Low, Dmitri Pchejetski
Oestrogen receptor-regulated glutathione S-transferase mu 3 expression attenuates hydrogen peroxide-induced cytotoxicity, which confers tamoxifen resistance on breast cancer cells
Juo-Han Lin, Shih-Hsin Tu, Li-Ching Chen, Chi-Cheng Huang, Hang-Lung Chang, Tzu-Chun Cheng, Hui-Wen Chang, Chih-Hsiung Wu, Han-Chung Wu, Yuan-Soon Ho
Clinicopathological and prognostic significance of Ras association and pleckstrin homology domains 1 (RAPH1) in breast cancer
Sasagu Kurozumi, Chitra Joseph, Sultan Sonbul, Mohammed A. Aleskandarany, Marian Pigera, Mansour Alsaleem, Sami Alsaeed, Yousif Kariri, Christopher C. Nolan, Maria Diez-Rodriguez, Simon Johnston, Nigel P. Mongan, Takaaki Fujii, Ken Shirabe, Stewart G. Martin, Ian O. Ellis, Andrew R. Green, Emad A. Rakha
Combination of anthracyclines and anti-CD47 therapy inhibit invasive breast cancer growth while preventing cardiac toxicity by regulation of autophagy
Yismeilin R. Feliz-Mosquea, Ashley A. Christensen, Adam S. Wilson, Brian Westwood, Jasmina Varagic, Giselle C. Meléndez, Anthony L. Schwartz, Qing-Rong Chen, Lesley Mathews Griner, Rajarshi Guha, Craig J. Thomas, Marc Ferrer, Maria J. Merino, Katherine L. Cook, David D. Roberts, David R. Soto-Pantoja
Perometry versus simulated circumferential tape measurement for the detection of breast cancer-related lymphedema
Fangdi Sun, Alexander Hall, Megan P. Tighe, Cheryl L. Brunelle, Hoda E. Sayegh, Tessa C. Gillespie, Kayla M. Daniell, Alphonse G. Taghian
The clinical relevance of serum vascular endothelial growth factor (VEGF) in correlation to circulating tumor cells and other serum biomarkers in patients with metastatic breast cancer
Malgorzata Banys-Paluchowski, Isabell Witzel, Sabine Riethdorf, Klaus Pantel, Brigitte Rack, Wolfgang Janni, Peter A. Fasching, Bahriye Aktas, Sabine Kasimir-Bauer, Andreas Hartkopf, Erich-Franz Solomayer, Tanja Fehm, Volkmar Müller
Randomized controlled trial of weight loss versus usual care on telomere length in women with breast cancer: the lifestyle, exercise, and nutrition (LEAN) study
Tara Sanft, Ilana Usiskin, Maura Harrigan, Brenda Cartmel, Lingeng Lu, Fang-Yong Li, Yang Zhou, Anees Chagpar, Leah M. Ferrucci, Lajos Pusztai, Melinda L. Irwin
Clinical subtypes and prognosis of pregnancy-associated breast cancer: results from the Korean Breast Cancer Society Registry database
Soo Youn Bae, Sei Joong Kim, JungSun Lee, Eun Sook Lee, Eun-Kyu Kim, Ho Young Park, Young Jin Suh, Hong Kyu Kim, Ji-Young You, Seung Pil Jung
Intra-tumor molecular heterogeneity in breast cancer: definitions of measures and association with distant recurrence-free survival
Ashirbani Saha, Michael R. Harowicz, Elizabeth Hope Cain, Allison H. Hall, Eun-Sil Shelley Hwang, Jeffrey R. Marks, Paul Kelly Marcom, Maciej A. Mazurowski
Screening status, tumour subtype, and breast cancer survival: a national population-based analysis
Katie M. O’Brien, Therese Mooney, Patricia Fitzpatrick, Linda Sharp
Cost-effectiveness of monitoring endoxifen levels in breast cancer patients adjuvantly treated with tamoxifen
M. van Nuland, R. A. Vreman, R. M. T. ten Ham, A. H. M. de Vries Schultink, H. Rosing, J. H. M. Schellens, J. H. Beijnen, A. M. Hövels
The yield of full BRCA1/2 genotyping in Israeli high-risk breast/ovarian cancer patients who do not carry the predominant mutations
Inbal Barnes-Kedar, Rinat Bernstein-Molho, Nava Ginzach, Shulamit Hartmajer, Tamar Shapira, Nurit Magal, Marina Lifshitc Kalis, Tamar Peretz, Mordechai Shohat, Lina Basel-Salmon, Eitan Friedman, Lily Bazak, Yael Goldberg
Sexual health in long-term breast cancer survivors
Sara V. Soldera, Marguerite Ennis, Ana E. Lohmann, Pamela J. Goodwin
Determinants of non-adherence to adjuvant endocrine treatment in women with breast cancer: the role of comorbidity
W. Wulaningsih, H. Garmo, J. Ahlgren, L. Holmberg, Y. Folkvaljon, A. Wigertz, M. Van Hemelrijck, M. Lambe
De novo vitamin D supplement use post-diagnosis is associated with breast cancer survival
J. M. Madden, L. Murphy, L. Zgaga, K. Bennett
Impact of race, ethnicity, and socioeconomic factors on receipt of radiation after breast conservation surgery: analysis of the national cancer database
Arti Parekh, Wei Fu, Chen Hu, Colette J. Shen, Sara Alcorn, Avani D. Rao, Fariba Asrari, Melissa S. Camp, Jean L. Wright
Pro-inflammatory cytokines and growth factors in human milk: an exploratory analysis of racial differences to inform breast cancer etiology
Jeanne Murphy, Ruth M. Pfeiffer, Brittny C. Davis Lynn, Ana I. Caballero, Eva P. Browne, Elizabeth C. Punska, Hannah P. Yang, Roni T. Falk, Douglas L. Anderton, Gretchen L. Gierach, Kathleen F. Arcaro, Mark E. Sherman
Onco-metabolism: defining the prognostic significance of obesity and diabetes in women with brain metastases from breast cancer
Neal S. McCall, Brittany A. Simone, Minesh Mehta, Tingting Zhan, Kevin Ko, Kamila Nowak-Choi, Annaisabel Rese, Chantel Venkataraman, David W. Andrews, Pramila R. Anne’, Adam P. Dicker, Wenyin Shi, Nicole L. Simone
Population-based validation of the National Cancer Comprehensive Network recommendations for breast cancer staging
Omar Abdel-Rahman
Towards treatment personalisation in triple negative breast cancer: role of platinum-based neoadjuvant chemotherapy
Mattia Rediti, Carlo Messina
Heterogeneity of tumor cells and metastases in breast cancer patients: cause or consequence?
Darko Zdravkovic, Dejan Nikolic, Marija Zdravkovic
Glucocorticoids in breast cancer treatment: real benefit or selection bias?
Gurkan Guner, Omer Dizdar
Rebuttal comments on “Glucocorticoids in breast cancer treatment: Real benefit or selection bias?”
Ching-Hung Lin, Chao-Hsiun Tang